MARKET

VERU

VERU

VERU
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.080
+0.010
+0.48%
Closed 16:00 10/14 EDT
OPEN
2.050
PREV CLOSE
2.070
HIGH
2.100
LOW
1.990
VOLUME
25.55K
TURNOVER
--
52 WEEK HIGH
2.490
52 WEEK LOW
1.180
MARKET CAP
135.28M
P/E (TTM)
-7.2651
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VERU and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VERU News

  • Veru (NASDAQ:VERU) Shareholders Have Enjoyed A 93% Share Price Gain
  • Simply Wall St..4d ago
  • Veru (VERU) Presents At Cantor Healthcare Conference - Slideshow
  • Seeking Alpha - Article.10/04 14:44
  • Veru Announces Full Enrollment of Phase 2 Trial in Men with Prostate Cancer Treatment Induced Hot Flashes
  • GlobeNewswire.10/02 11:30
  • Veru provides update on zuclomiphene citrate
  • Seeking Alpha - Article.10/02 10:59

More

Industry

Pharmaceuticals
-0.01%
Pharmaceuticals & Medical Research
+0.09%

Hot Stocks

Name
Price
%Change

About VERU

Veru Inc., formerly The Female Health Company, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men's and women's health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector. For men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout and sexual dysfunction. Women's Health has product candidates for female sexual health, and advanced breast and ovarian cancers. It manufactures, markets and sells the FC2 Female Condom. FC2 provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS).
More

Webull offers Veru Inc (VERU) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.